76 related articles for article (PubMed ID: 15026413)
41. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.
Hashimoto M; Rockenstein E; Mante M; Crews L; Bar-On P; Gage FH; Marr R; Masliah E
Gene Ther; 2004 Dec; 11(23):1713-23. PubMed ID: 15483670
[TBL] [Abstract][Full Text] [Related]
42. Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.
Hashimoto M; Takenouchi T; Rockenstein E; Masliah E
J Neurochem; 2003 Jun; 85(6):1468-79. PubMed ID: 12787066
[TBL] [Abstract][Full Text] [Related]
43. alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.
Hashimoto M; Hsu LJ; Rockenstein E; Takenouchi T; Mallory M; Masliah E
J Biol Chem; 2002 Mar; 277(13):11465-72. PubMed ID: 11790792
[TBL] [Abstract][Full Text] [Related]
44. Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway.
Seo JH; Rah JC; Choi SH; Shin JK; Min K; Kim HS; Park CH; Kim S; Kim EM; Lee SH; Lee S; Suh SW; Suh YH
FASEB J; 2002 Nov; 16(13):1826-8. PubMed ID: 12223445
[TBL] [Abstract][Full Text] [Related]
45. alpha-Synuclein forms a complex with transcription factor Elk-1.
Iwata A; Miura S; Kanazawa I; Sawada M; Nukina N
J Neurochem; 2001 Apr; 77(1):239-52. PubMed ID: 11279280
[TBL] [Abstract][Full Text] [Related]
46. Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease.
Hashimoto M; Bar-On P; Ho G; Takenouchi T; Rockenstein E; Crews L; Masliah E
J Biol Chem; 2004 May; 279(22):23622-9. PubMed ID: 15026413
[TBL] [Abstract][Full Text] [Related]
47. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
Hegde ML; Jagannatha Rao KS
Arch Biochem Biophys; 2003 Oct; 418(2):169-78. PubMed ID: 14522588
[TBL] [Abstract][Full Text] [Related]
48. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
49. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
50. Parkinson's disease and other alpha-synucleinopathies.
Goedert M
Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
[TBL] [Abstract][Full Text] [Related]
51. α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.
Braithwaite SP; Stock JB; Mouradian MM
Rev Neurosci; 2012 Mar; 23(2):191-8. PubMed ID: 22499677
[TBL] [Abstract][Full Text] [Related]
52. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Krüger R; Müller T; Riess O
J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
[TBL] [Abstract][Full Text] [Related]
53. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
[TBL] [Abstract][Full Text] [Related]
54. The cellular pathology of Parkinson's disease.
Takahashi H; Wakabayashi K
Neuropathology; 2001 Dec; 21(4):315-22. PubMed ID: 11837539
[TBL] [Abstract][Full Text] [Related]
55. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
Norris EH; Giasson BI
Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
[TBL] [Abstract][Full Text] [Related]
56. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
57. Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease?
Rajagopalan S; Andersen JK
Mech Ageing Dev; 2001 Sep; 122(14):1499-510. PubMed ID: 11511392
[TBL] [Abstract][Full Text] [Related]
58. Alpha-synuclein aggregation.
Bodles AM; Irvine GB
Protein Pept Lett; 2004 Jun; 11(3):271-9. PubMed ID: 15182228
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
